<DOC>
	<DOCNO>NCT02475616</DOCNO>
	<brief_summary>This single-center , placebo-controlled , randomize , double-blind , dose-escalation study evaluate safety , tolerability , PK single oral ( PO ) administration PCO371 healthy adult male . Caucasian Japanese subject randomize receive either PCO371 placebo .</brief_summary>
	<brief_title>A Single Ascending Dose Study PCO371 Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy male volunteer age 18 45 year . Caucasian ( BMI 1830 mg/kg2 ) first generation japanese ( BMI 1825kg/m2 ) Able willing abide protocol Evidence medical condition could affect renal , hepatic , cardiopulmonary function .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>